{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T22:52:12Z","timestamp":1781304732064,"version":"3.54.1"},"reference-count":0,"publisher":"Oxford University Press (OUP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1997,3,1]]},"DOI":"10.1093\/rheumatology\/36.3.353","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T18:38:32Z","timestamp":1027708712000},"page":"353-359","source":"Crossref","is-referenced-by-count":99,"title":["Thalidomide in the treatment of the cutaneous manifestations of lupus erythematosus: experience in sixteen consecutive patients"],"prefix":"10.1093","volume":"36","author":[{"given":"R.","family":"Stevens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","container-title":["Rheumatology"],"original-title":[],"link":[{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/36\/3\/353\/18105163\/360353.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,23]],"date-time":"2017-08-23T22:57:54Z","timestamp":1503529074000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-lookup\/doi\/10.1093\/rheumatology\/36.3.353"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,3,1]]},"references-count":0,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/36.3.353","relation":{},"ISSN":["1460-2172"],"issn-type":[{"value":"1460-2172","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,3,1]]}}}